logo
Plus   Neg
Share
Email

Merck Gets Positive CHMP Opinion For Prevymis In EU - Quick Facts

Merck & Co. Inc. (MRK), known as MSD outside the U.S. and Canada, said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency has adopted a positive opinion recommending approval of Prevymis (letermovir) for prophylaxis of cytomegalovirus or CMV reactivation and disease in adult CMV-seropositive recipients [R+] of an allogeneic haematopoietic stem cell transplant (HSCT).

The CHMP positive opinion will be considered by the European Commission. If the CHMP opinion is affirmed, the EC will grant a centralized marketing authorization with unified labeling that is valid in the 28 countries of the European Union or EU, as well as European Economic Area members, Iceland, Liechtenstein and Norway.

Merck said it expects that the European Commission decision will be adopted within approximately two months.

In the pivotal Phase 3 clinical trial evaluating letermovir, significantly fewer patients in the Prevymis arm compared to the placebo arm developed clinically significant CMV infection, discontinued treatment or had missing data through Week 24 post-HSCT, the primary efficacy endpoint.

Prevymis was approved by the U.S. Food and Drug Administration or FDA on November 8. In the U.S., Prevymis is indicated for prophylaxis of cytomegalovirus infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant.

Merck also has filed letermovir for regulatory approval in other markets including Japan, where it is currently under review.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Alphabet's subsidiary Loon LLC has secured its first commercial deal - to deliver 4G internet access to remote areas of Kenya using high-altitude balloons. Loon will partner with Telkom Kenya to deliver connectivity to parts of Kenya. Telkom Kenya announced Thursday that it has signed a definitive agreement with Loon to pilot a new 4G/LTE access network service in Kenya. The Cow Calendar era is coming to an end. Chick-fil-A said it is axing one of its well-loved products, the Cow Calendar. The 2018 Cow Calendar will be the chicken chain's last calendar. Chick-fil-A first launched the Cow Calendar in 1998 that featured cows as a new tool to convince people to eat more chicken. The calendars were popular not just for the pictures of funny Chick-fil-A cows. Japanese telecom giant Nippon Telegraph and Telephone or NTT has filed a patent for a blockchain technology-based new contract agreement method. NTT, the world's fourth-largest telecom provider, explains the ways to use the application to store contracts without tampering documents.
Follow RTT